Indium DTPA In 111
Generic: INDIUM IN-111 PENTETATE DISODIUM
Basic Information
Manufacturer
Medi-Physics, Inc. dba GE Healthcare
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRATHECAL
FDA Set ID
4fea5871-b515-4f69-a297-11507ddd7817
Indications & Usage
INDICATIONS AND USAGE Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.
Warnings
WARNINGS The contents of the vial are radioactive.
Adequate shielding of the preparation must be maintained at all times.
Since the drug is excreted by the kidneys, caution should be exercised in patients with severely impaired renal function.
Adequate shielding of the preparation must be maintained at all times.
Since the drug is excreted by the kidneys, caution should be exercised in patients with severely impaired renal function.
Adverse Reactions
ADVERSE REACTIONS Aseptic meningitis and pyrogenic reactions have been rarely (less than 0.4%) observed following cisternography with Pentetate lndium Disodium In 111.
One death has been reported to have occurred within 20 minutes following the administration of Pentetate Indium Disodium In 111 and appears to be drug related.
In addition, two cases of septic meningitis have also been reported.
There have also been reports of skin reactions and vomiting following administration of Pentetate lndium Disodium In 111.
Relationship of the drug to these latter occurrences has not been established.
One death has been reported to have occurred within 20 minutes following the administration of Pentetate Indium Disodium In 111 and appears to be drug related.
In addition, two cases of septic meningitis have also been reported.
There have also been reports of skin reactions and vomiting following administration of Pentetate lndium Disodium In 111.
Relationship of the drug to these latter occurrences has not been established.